🔗 Share this article

An underground market for unapproved slimming drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.

Experimental Treatment Gaining Popularity Online

The experimental drug, which is still in clinical trials, is being advertised by online personalities for its alleged fat-burning effects. Followers are urged to message these profiles privately for supplier links, while also obtaining discount codes.

Active Trade on Messaging Platforms

Separately, a robust market exists on Telegram, where communities with numerous of members share “before and after” photos, administration instructions and assertions of rapid UK delivery. Vendors promote the substance there before directing buyers to other platforms for transactions.

Understanding The Experimental Drug

Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Early trials suggest it could help patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the substance is being hailed digitally as the next Ozempic.

Healthcare Experts Voice Concerns

Nevertheless, doctors and pharmacists have warned that the distribution of what remains an unapproved medication in the UK is a cause for concern and could result in users administering substances of uncertain source.

Some experts stated the popularity for the experimental drug could be linked to the rising cost of licensed weight loss treatments such as Mounjaro.

Regulatory Status and Implementation

Selling retatrutide on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that cannot be promoted or supplied for personal consumption under the British medical regulations.

Several influencers try to circumvent the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but advertising and supply can still violate pharmaceutical, advertising, and consumer laws, risking penalties, prosecution or imprisonment.

Platform Response and Content Removal

Based on the social media company, the platform has taken down violative material and banned associated hashtags and query recommendations. The organization stated it was committed to maintaining the service secure and allocating resources in strengthening enforcement strategies.

Online Trading Operations

Research also discovered communities with up to 9,000 participants selling the experimental drug using Telegram's integrated discovery tool, which operates like a public directory. Typing “retatrutide” immediately brings up groups with thousands of members, populated with photos of slimming results, glowing reviews and step-by-step guides for preparing or administering at home.

After minutes of entering one group, a vendor shared WhatsApp details, where the majority of purchases take place. The vendor provided an instruction manual and guaranteed shipping within 48 hours. When asked whether the product was authentic, one vendor said: “You can’t be sure.” Another provided a image of a supposed testing documentation. Not one asked about weight, medical conditions or past usage.

Item Details and Pricing

Within these communities, posts display black plastic packages with Royal Mail labels, stating to include new batches. One message read: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, prepared at home with purified liquid, or ready-to-use pens usually priced at 160 pounds for 20 milligrams. When asked how much time a injector should last, vendors give conflicting responses ranging from a several days to “depends on your body”.

Service Moderation and Safety Actions

A representative for the messaging service said it actively moderated harmful content on its service including material that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“Individuals are administering substances they can’t verify. Although the research behind retatrutide is valid, these online products may not include what they advertise,” stated a pharmacy expert, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in interest to recent price rises for authorized weight-loss drugs such as Mounjaro. “With costs increasing, patients are turning to social media. But fake injections are extremely dangerous. You cannot know what’s contained or whether the environment they were made in was clean,” she said.

Her staff has already seen individuals injured by personal administration from unverified sources. “We understand the frustration, but buying from Telegram or WhatsApp is gambling with your well-being,” stated the doctor. “These substances could be impure or incorrectly dosed.”

Manufacturer Statement

A representative from the pharmaceutical company stated retatrutide was in third stage clinical trials and had not been reviewed or approved by any regulatory agency globally. “Consequently at this time no one can market [it] for personal consumption,” they explained, noting that any product “misleadingly claiming itself as a Lilly experimental substance not yet approved … may expose patients to possibly significant medical dangers”.